Skip to main content
    A

    AngioDynamics Inc (ANGO)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $11.87
    -0.11 (-0.96%)

    Market Cap: $499.19M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    AngioDynamics Inc (ANGO) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect AngioDynamics (ANGO) to earn -$0.28 per share in the fiscal year ending May 31, 2027, on revenue of $337.70M. Over the last 30 days, 0 estimates for the fiscal year ending May 31, 2027 were revised up and 2 down. For the fiscal year ending May 31, 2028, the EPS consensus is -$0.11.

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus shows a smaller loss and revenue estimates rise 5.1%.

    Fiscal year ending May 31, 2027
    -$0.28
    EPS consensus, revenue $337.70M
    Fiscal year ending May 31, 2028
    -$0.11
    EPS consensus, revenue $354.91M
    Next report
    Jan 4, 2027
    Estimated

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    May 31, 2027-$0.28-$0.29 to -$0.273$337.70M$337.00M to $338.42M4
    May 31, 2028-$0.11-$0.15 to -$0.063$354.91M$352.00M to $360.12M4

    Quarterly Estimates

    Across the 3 quarters below, the EPS consensus is lowest for the quarter ending Feb 28, 2027, at -$0.09, and highest for the quarter ending May 31, 2027, at -$0.06.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Nov 30, 2026-$0.07-$0.11 to -$0.023$84.27M$83.00M to $85.40M4
    Feb 28, 2027-$0.09-$0.10 to -$0.073$83.25M$81.90M to $84.00M4
    May 31, 2027-$0.06-$0.10 to -$0.025$91.02M$86.24M to $95.03M6

    Estimate Revisions

    Across the 4 periods below, the last 30 days brought 2 upward and 5 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending May 31, 202702
    Fiscal year ending May 31, 202810
    Quarter ending Nov 30, 202611
    Quarter ending Feb 28, 202702

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending May 31, 2027 has worsened from -$0.27.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending May 31, 2027-$0.28-$0.27-$0.27-$0.27-$0.27N/A
    Fiscal year ending May 31, 2028-$0.11-$0.05-$0.05-$0.05-$0.05N/A
    Quarter ending Nov 30, 2026-$0.07-$0.08-$0.08-$0.08-$0.06N/A
    Quarter ending Feb 28, 2027-$0.09-$0.06-$0.06-$0.06-$0.06N/A

    Frequently Asked Questions About ANGO

    What is the ANGO stock forecast?

    Consensus analyst estimates put AngioDynamics's EPS at -$0.28 for the fiscal year ending May 31, 2027, on revenue of $337.70M.

    What EPS do analysts expect from ANGO next year?

    For the fiscal year ending May 31, 2027, the consensus EPS estimate is -$0.28, with estimates from -$0.29 to -$0.27 from 3 analysts. For the fiscal year ending May 31, 2028, the consensus EPS estimate is -$0.11, with estimates from -$0.15 to -$0.06 from 3 analysts.

    What revenue do analysts expect from AngioDynamics next year?

    For the fiscal year ending May 31, 2027, the consensus revenue estimate is $337.70M, with estimates from $337.00M to $338.42M. For the fiscal year ending May 31, 2028, the consensus revenue estimate is $354.91M, with estimates from $352.00M to $360.12M.

    How many analysts cover ANGO?

    3 analysts estimate EPS for AngioDynamics for the fiscal year ending May 31, 2027.